Windtree Therapeutics (WINT) Misses Q1 EPS by 12c

Windtree Therapeutics (NASDAQ: WINT) reported Q1 EPS of ($1.70), $0.12 worse than the analyst estimate of ($1.58). Revenue for the quarter came in at $75 thousand, versus $191 thousand reported last year.

For earnings history and earnings-related data on Windtree Therapeutics (WINT) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Elevance (ELV) PT Raised to $482 at Bernstein SocGen
• General Mills (GIS) PT Lowered to $42 at Freedom Broker